论文部分内容阅读
目的对双歧杆菌三联活菌预防婴幼儿肺炎继发性腹泻的临床治疗效果进行分析。方法 104例肺炎患儿,随机分为观察组与对照组,各52例。对照组患儿应用常规治疗方案,观察组在对照组基础上应用双歧杆菌三联活菌。对比两组治疗效果。结果观察组腹泻发生率显著低于对照组,腹泻严重程度轻于对照组,差异均有统计学意义(P<0.05);两组均未出现明显不良反应。结论肺炎患儿在常规基础上应用双歧杆菌三联活菌,能够明显降低婴幼儿肺炎继发性腹泻发生率及不良反应发生率,值得推广。
Objective To analyze the clinical efficacy of Bifidobacterium triple viable bacteria in the prevention of secondary diarrhea in infants with pneumonia. Methods 104 cases of children with pneumonia were randomly divided into observation group and control group, 52 cases each. The control group of children with conventional treatment programs, the observation group in the control group based on the application of Bifidobacterium triple viable bacteria. Compare the two groups treatment effect. Results The incidence of diarrhea in the observation group was significantly lower than that in the control group, and the severity of diarrhea was lower than that in the control group (P <0.05). No obvious adverse reactions occurred in both groups. Conclusion The application of Bifidobacterium triple viable bacteria in children with pneumonia on the routine basis can significantly reduce the incidence of secondary diarrhea and adverse reactions of pneumonia in infants and young children and is worth popularizing.